90 related articles for article (PubMed ID: 6156420)
1. Kinetics of 5-aza-2'-deoxycytidine phosphorylation in mouse spleen and L1210 leukemic cell extracts.
Veselý J; Cihák A
Neoplasma; 1980; 27(2):121-7. PubMed ID: 6156420
[TBL] [Abstract][Full Text] [Related]
2. High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity.
Veselý J
Neoplasma; 1987; 34(6):713-20. PubMed ID: 2448662
[TBL] [Abstract][Full Text] [Related]
3. Effects of the alpha-D-anomer of 5-aza-2'-deoxycytidine on L1210 mouse leukemic cells in vitro and in vivo.
Veselý J; Pískala A
Cancer Res; 1984 Nov; 44(11):5165-8. PubMed ID: 6207913
[TBL] [Abstract][Full Text] [Related]
4. Incorporation of a potent antileukemic agent, 5-aza-2'-deoxycytidine, into DNA of cells from leukemic mice.
Veselý J; Cihák A
Cancer Res; 1977 Oct; 37(10):3684-9. PubMed ID: 71199
[TBL] [Abstract][Full Text] [Related]
5. 5-Aza-2'-deoxycytidine: preclinical studies in mice.
Veselý J; Cihák A
Neoplasma; 1980; 27(2):113-9. PubMed ID: 6156419
[TBL] [Abstract][Full Text] [Related]
6. 3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.
Raynal NJ; Momparler LF; Rivard GE; Momparler RL
Leuk Res; 2011 Jan; 35(1):110-8. PubMed ID: 20510451
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of DNA methylation in L1210 leukemic cells by 5-aza-2'-deoxycytidine as a possible mechanism of chemotherapeutic action.
Wilson VL; Jones PA; Momparler RL
Cancer Res; 1983 Aug; 43(8):3493-6. PubMed ID: 6190553
[TBL] [Abstract][Full Text] [Related]
8. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
[TBL] [Abstract][Full Text] [Related]
9. Cellular phosphorylation of 1-beta-D-arabinofuranosylcytosine 5-azacytidine with intact fibrosarcoma and leukemic cells.
Lee T; Karon M; Monparler RL
Cancer Res; 1975 Sep; 35(9):2506-10. PubMed ID: 50132
[TBL] [Abstract][Full Text] [Related]
10. Effects of 5-aza-2'-deoxycytidine on DNA synthesis in mouse lymphatic tissues.
Cihák A; Veselý J
Neoplasma; 1978; 25(4):385-93. PubMed ID: 80754
[TBL] [Abstract][Full Text] [Related]
11. DNA alkali-labile sites induced by incorporation of 5-aza-2'-deoxycytidine into DNA of mouse leukemia L1210 cells.
D'Incalci M; Covey JM; Zaharko DS; Kohn KW
Cancer Res; 1985 Jul; 45(7):3197-202. PubMed ID: 2408746
[TBL] [Abstract][Full Text] [Related]
12. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
Momparler RL; Veselý J; Momparler LF; Rivard GE
Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
[TBL] [Abstract][Full Text] [Related]
13. Role of deoxycytidine kinase in an in vitro model for AraC- and DAC-resistance: substrate-enzyme interactions with deoxycytidine, 1-beta-D-arabinofuranosylcytosine and 5-aza-2'-deoxycytidine.
Stegmann AP; Honders MW; Kester MG; Landegent JE; Willemze R
Leukemia; 1993 Jul; 7(7):1005-11. PubMed ID: 7686601
[TBL] [Abstract][Full Text] [Related]
14. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
Li ZR; Campbell J; Rustum YM
Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
[TBL] [Abstract][Full Text] [Related]
15. Combinational chemotherapy of L1210 and L1210/ARA-C leukemia with 5-AZA-2'-deoxycytidine and beta-2'-deoxythioguanosine.
Momparler RL; Momparler LF; Samson J
Int J Cancer; 1982 Sep; 30(3):361-64. PubMed ID: 6182115
[TBL] [Abstract][Full Text] [Related]
16. Properties of uridine-cytidine kinase derived from L1210 leukemia cells.
Ahmed NK; Baker DR
Cancer Res; 1980 Oct; 40(10):3559-63. PubMed ID: 6254634
[TBL] [Abstract][Full Text] [Related]
17. Depression of DNA synthesis in mouse spleen after treatment with 5-aza-2'-deoxycytidine.
Cihák A; Veselý J
J Natl Cancer Inst; 1979 Oct; 63(4):1035-9. PubMed ID: 90150
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of phosphorylation of 5-aza-2'-deoxyycytidine by deoxycytidine kinase.
Momparler RL; Derse D
Biochem Pharmacol; 1979 Apr; 28(8):1443-4. PubMed ID: 87202
[No Abstract] [Full Text] [Related]
19. Chemotherapy of L1210 and L1210/ARA-C leukemia with 5-aza-2'-deoxycytidine and 3-deazauridine.
Momparler RL; Momparler LF
Cancer Chemother Pharmacol; 1989; 25(1):51-4. PubMed ID: 2480188
[TBL] [Abstract][Full Text] [Related]
20. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
Grant S; Rauscher F; Margolin J; Cadman E
Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
